BioCentury
ARTICLE | Company News

Gill named CEO of TransCelerate

December 11, 2012 2:12 AM UTC

TransCelerate BioPharma Inc. (Philadelphia, Pa.) named Dalvir Gill as CEO, effective Jan. 1, 2013. Gill was president of Phase II-IV drug development at CRO PharmaNet Development Group Inc. Gill succeeds Garry Neil, who has been serving as interim CEO since the not-for-profit was formed in September. Neil will remain as chairman.

TransCelerate was launched by 10 pharmas to identify and solve common drug development challenges to improve the quality of clinical trials and accelerate drug development (see BioCentury, Oct. 1). ...